Paper20111963
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
Brom M and 4 others. Eur J Nucl Med Mol Imaging, 2010. Cited by 113 papers, by iCite.
Cite this record
ConductScience Library. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET. Papers, record 20111963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20111963
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulinoma | Major topic |
| Peptides | Major topic |
| Positron-Emission Tomography | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Biological Transport | |
| Cell Line, Tumor | |
| Dose-Response Relationship, Drug | |
| Female | |
| Gallium Radioisotopes | |
| Heterocyclic Compounds, 1-Ring | |
| Inhibitory Concentration 50 | |
| Injections | |
| Kinetics | |
| Lysine | |
| Mice | |
| Molecular Sequence Data | |
| Pentetic Acid | |
| Rats |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AG030328 | NIA NIH HHS | United States | R01AG030328 | PubMed and NIH |
| 1R01 AG 030328-01 | NIA NIH HHS | United States | R01AG030328 | PubMed and NIH |
Source NIH RePORTER
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9024313 | Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). | Gastroenterology | 1997 | https://conductscience.org/library/papers/9024313 | PubMed |
| 2 | 17227804 | Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. | J Clin Endocrinol Metab | 2007 | https://conductscience.org/library/papers/17227804 | PubMed |
| 3 | 17225119 | Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? | Eur J Nucl Med Mol Imaging | 2007 | https://conductscience.org/library/papers/17225119 | PubMed |
| 4 | 10382845 | In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera. | Nucl Med Biol | 1999 | https://conductscience.org/library/papers/10382845 | PubMed |
| 5 | 17138746 | [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. | J Nucl Med | 2006 | https://conductscience.org/library/papers/17138746 | PubMed |
| 6 | 15763697 | Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours. | Best Pract Res Clin Endocrinol Metab | 2005 | https://conductscience.org/library/papers/15763697 | PubMed |
| 7 | 17575235 | [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17575235 | PubMed |
| 8 | 18205253 | Occult sporadic insulinoma: localization and surgical strategy. | World J Gastroenterol | 2008 | https://conductscience.org/library/papers/18205253 | PubMed |
| 9 | 16930741 | A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents. | Regul Pept | 2006 | https://conductscience.org/library/papers/16930741 | PubMed |
| 10 | 10774879 | Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. | Eur J Nucl Med | 2000 | https://conductscience.org/library/papers/10774879 | PubMed |
| 11 | 14499161 | Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. | Mol Imaging Biol | 2003 | https://conductscience.org/library/papers/14499161 | PubMed |
| 12 | 17934729 | Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin. | Eur J Nucl Med Mol Imaging | 2008 | https://conductscience.org/library/papers/17934729 | PubMed |
| 13 | 18703486 | Glucagon-like peptide 1-receptor scans to localize occult insulinomas. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18703486 | PubMed |
| 14 | 1370150 | Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. | Endocrinology | 1992 | https://conductscience.org/library/papers/1370150 | PubMed |
| 15 | 7905200 | [Receptor scintigraphy using 111In-pentetreotide in endocrine gastroenteropancreatic tumors]. | Nuklearmedizin | 1993 | https://conductscience.org/library/papers/7905200 | PubMed |
| 16 | 8563978 | Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. | Eur J Neurosci | 1995 | https://conductscience.org/library/papers/8563978 | PubMed |
| 17 | 7800858 | Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig. | Regul Pept | 1994 | https://conductscience.org/library/papers/7800858 | PubMed |
| 18 | 11976797 | Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results. | Eur J Nucl Med Mol Imaging | 2002 | https://conductscience.org/library/papers/11976797 | PubMed |
| 19 | 8404961 | Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. | Eur J Nucl Med | 1993 | https://conductscience.org/library/papers/8404961 | PubMed |
| 20 | 17520251 | Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. | Eur J Nucl Med Mol Imaging | 2007 | https://conductscience.org/library/papers/17520251 | PubMed |
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42380410 | High-yield, standardised automated radiosynthesis process for routine clinical insulinoma PET with [⁶⁸Ga]Ga-NODAGA-exendin-4. | EJNMMI Radiopharm Chem | 2026 | https://conductscience.org/library/papers/42380410 | PubMed |
| 41223138 | 68 Ga-NODAGA-EXENDIN-4 PET/CT in the Detection or the Exclusion of Occult Sporadic Insulinomas. | Clin Nucl Med | 2025 | https://conductscience.org/library/papers/41223138 | PubMed |
| 41088364 | Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41088364 | PubMed |
| 40796705 | [68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism. | EJNMMI Res | 2025 | https://conductscience.org/library/papers/40796705 | PubMed |
| 40591218 | 212Pb in targeted radionuclide therapy: a review. | EJNMMI Radiopharm Chem | 2025 | https://conductscience.org/library/papers/40591218 | PubMed |
| 40281248 | GLP- 1R status using validated monoclonal antibody in 689 cases of neuroendocrine neoplasm and its correlation with somatostatin receptor scintigraphy, insulin production, and histological grades. | Virchows Arch | 2025 | https://conductscience.org/library/papers/40281248 | PubMed |
| 40145271 | Characterization of the Pancreatic Neuroendocrine Neoplasm Immune Microenvironment. | Cancer Med | 2025 | https://conductscience.org/library/papers/40145271 | PubMed |
| 38227104 | Characterization and comparison of insulinoma tumor model and pancreatic damage caused by the tumor, and identification of possible markers. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38227104 | PubMed |
| 37780209 | Theranostic in GLP-1R molecular imaging: challenges and emerging opportunities. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37780209 | PubMed |
| 34695532 | Translational challenges in pancreatic neuroendocrine tumor immunotherapy. | Biochim Biophys Acta Rev Cancer | 2021 | https://conductscience.org/library/papers/34695532 | PubMed |
| 34432147 | Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents? | EJNMMI Radiopharm Chem | 2021 | https://conductscience.org/library/papers/34432147 | PubMed |
| 34248856 | Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34248856 | PubMed |
| 34215672 | 68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism. | J Nucl Med | 2022 | https://conductscience.org/library/papers/34215672 | PubMed |
| 31951592 | Innovative imaging of insulinoma: the end of sampling? A review. | Endocr Relat Cancer | 2020 | https://conductscience.org/library/papers/31951592 | PubMed |
| 31924726 | Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW. | J Nucl Med | 2020 | https://conductscience.org/library/papers/31924726 | PubMed |
| 31903131 | Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics. | Theranostics | 2020 | https://conductscience.org/library/papers/31903131 | PubMed |
| 31394799 | A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling? | Molecules | 2019 | https://conductscience.org/library/papers/31394799 | PubMed |
| 31378283 | Molecular imaging of β-cells: diabetes and beyond. | Adv Drug Deliv Rev | 2019 | https://conductscience.org/library/papers/31378283 | PubMed |
| 31370679 | Noninvasive longitudinal quantification of β-cell mass with [111In]-labeled exendin-4. | FASEB J | 2019 | https://conductscience.org/library/papers/31370679 | PubMed |
| 31163066 | Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model. | PLoS One | 2019 | https://conductscience.org/library/papers/31163066 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 | NCBI Gene |
| SSTR5 | 6755 | PubTator's text mining | https://conductscience.org/library/genes/6755 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20111963
GET https://conductscience.org/api/papers/v1/20111963/references?page=2